(FTCS) Capital Strength - Overview
Etf: Equity, Large-Cap, Index-Based, Stability
Dividends
| Dividend Yield | 1.06% |
| Yield on Cost 5y | 1.50% |
| Yield CAGR 5y | 1.93% |
| Payout Consistency | 96.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 9.15% |
| Relative Tail Risk | 1.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | 0.70 |
| Character TTM | |
|---|---|
| Beta | 0.536 |
| Beta Downside | 0.480 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.62% |
| CAGR/Max DD | 0.91 |
Description: FTCS Capital Strength January 06, 2026
The First Trust Capital Strength ETF (FTCS) commits at least 90% of its net assets-including any investment borrowings-to the securities that compose its underlying index, which targets well-capitalized firms with strong market positions that aim to deliver greater stability and long-term performance for shareholders.
As of the most recent quarter, FTCS carries an expense ratio of 0.35% and manages roughly $1.2 billion in assets. Its top holdings are heavily weighted toward large-cap technology and healthcare leaders such as Apple, Microsoft, and Johnson & Johnson, reflecting a sector composition of about 45% information technology and 20% health care. The index’s “capital strength” methodology scores companies on metrics like debt-to-equity, return on equity, and free-cash-flow yield-factors that tend to outperform in a low-interest-rate environment where capital efficiency is prized.
For a deeper dive into how FTCS fits into a value-oriented portfolio, you might explore the analytics on ValueRay.
What is the price of FTCS shares?
Over the past week, the price has changed by +2.42%, over one month by +5.02%, over three months by +9.75% and over the past year by +11.07%.
Is FTCS a buy, sell or hold?
What are the forecasts/targets for the FTCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 109.4 | 10.4% |
FTCS Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 8.22b USD (8.22b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 8.22b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 8.22b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.89% (E(8.22b)/V(8.22b) * Re(7.89%) + (debt-free company))
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)